SEC Form 4 · accession 0001209191-16-131549
Insys Therapeutics, Inc. · INSY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven J Meyer
Director
Period of report
Jul 6, 2016
Accepted (ET)
Jul 6, 2016 · 4:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001516479
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 6, 2016 | M | 695 | $14.44 | A | 32,389 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $14.44 | Jul 6, 2016 | M | 695 | D | — | May 1, 2026 | Common Stock | 695 | 23,611 | D |
Explanation of responses
- F1The option vests in 36 equal monthly installments and will be fully vested and exercisable on May 2, 2019.